Literature DB >> 30529326

Efficient drug discovery by rational lead hybridization based on crystallographic overlay.

Shuo Zhang1, Jian Zhang1, Ping Gao1, Lin Sun1, Yuning Song2, Dongwei Kang3, Xinyong Liu4, Peng Zhan5.   

Abstract

In this review, we provide an overview of recent applications of crystallographic overlay-based molecular structure hybridization of lead compounds as a rational strategy for efficient drug discovery, with selected examples, and briefly discuss its advantages compared with other ligand-based methodologies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2018        PMID: 30529326     DOI: 10.1016/j.drudis.2018.11.021

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  3 in total

Review 1.  Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

Authors:  Francesc Xavier Ruiz; Eddy Arnold
Journal:  Curr Opin Struct Biol       Date:  2020-01-11       Impact factor: 6.809

2.  Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1.

Authors:  F Xavier Ruiz; Anthony Hoang; Kalyan Das; Eddy Arnold
Journal:  J Med Chem       Date:  2019-10-25       Impact factor: 7.446

Review 3.  Drug discovery in leishmaniasis using protein lipidation as a target.

Authors:  James A Brannigan; Anthony J Wilkinson
Journal:  Biophys Rev       Date:  2021-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.